News Details

 

Exasol AG sets issue price for IPO at 9.50 euros per share

EXASOL AG / Key word(s): IPO
Exasol AG sets issue price for IPO at 9.50 euros per share

19-May-2020 / 19:40 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.


Inside information pursuant to Article 17 of Regulation (EU) No 596/2014

Exasol AG sets issue price for IPO at 9.50 euros per share

  • Total volume of shares offered in the IPO including over-allotment option and upsize option significantly oversubscribed for the issue price

Nuremberg, 19 May 2020 - Exasol AG (ISIN: DE000A0LR9G9; www.exasol.com), a global technology company providing a next generation software-based "data engine", has set the issue price for its shares offered in the IPO at 9.50 euros. At the issue price, the total volume of Exasol AG shares offered was significantly oversubscribed.

The offering comprised 5,100,000 newly issued shares from a cash capital increase, 2,035,000 existing shares from the holdings of the existing shareholder KfW and Exasol AG, as well as 1,070,250 existing shares in connection with a standard market over-allotment option and 1,000,000 existing shares in connection with an upsize option. All 9,205,250 shares offered were placed. The placement volume including the over-allotment option and upsize option thus amounts to approximately 87.45 million Euro.

Exasol AG plans to use the proceeds from the IPO to further drive its growth strategy. They will be used primarily to enhance sales force as well as distribution and marketing power in the DACH (Germany, Austria, Switzerland) region, the UK and the US, and to further invest in research and development initiatives.

The start of trading in the European growth segment "Scale" of the Frankfurt Stock Exchange is planned for 25 May 2020, as is the delivery of the offered shares. The shares of Exasol AG have the international securities identification number (ISIN) DE000A0LR9G9, the German "Wertpapierkennnummer" (WKN) A0LR9G and the ticker symbol EXL.

Hauck & Aufhäuser acts as Sole Global Coordinator and Sole Bookrunner in the IPO.

Exasol contact
Dr. Katharina Berger, Legal Counsel
Phone: + 49 911 23991327
Email: Katharina.berger@exasol.com

About Exasol

Exasol is the analytics database. Its high-performance in-memory analytics database gives organizations the power to transform how they work with data, on-premises, in the cloud or both - and turn it into value faster, easier and more cost effectively than ever before.

To learn more about Exasol please visit www.exasol.com

Important Notice

This announcement does not contain or constitute an offer to sell nor a solicitation to buy or subscribe for securities.

This announcement is not a prospectus. Potential investors should not purchase or subscribe for any securities referred to in this announcement except on the basis of the information contained in the prospectus of the Company (including any supplements thereto) which has been approved by the German federal financial supervisory authority (Bundesanstalt für Finanzdienstleistungsaufsicht - BaFin) and immediately published thereafter. Copies of such prospectus are available free of charge from Exasol AG, as well as, for viewing in electronic form, on the website of the Company.

This announcement is not an offer of securities for sale in the United States of America (the "United States"). Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Any public offering of securities to be made in the United States would be made by means of a prospectus that could be obtained from the Company and that would contain detailed information about the Company and its management, as well as the financial statements of the Company. There will be no public offer of the securities in the United States.

In the United Kingdom, this information is directed at and/or for distribution only to (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) high net worth companies falling within article 49(2)(a) to (d) of the Order (all such persons are collectively referred to herein as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this information or any of its contents.

In member states of the European Economic Area ("EEA"), in which the Regulation (EU) 2017/1129 as amended (the "Prospectus Regulation") is in effect other than Germany and the United Kingdom (the "Relevant Member States"), this announcement, and any offer following it, is only addressed to persons who are 'qualified investors' within the meaning of Article 2(e) of the Prospectus Regulation ("Qualified Investors"). It is assumed that each person in the Relevant Member States who acquires or is offered securities as part of an offering (an "Investor") has represented and agreed that such person is a Qualified Investor; that securities purchased by such person as part of the offering are not being purchased for any person in the EEA other than a Qualified Investor or persons in Germany, the United Kingdom or another Relevant Member State with comparable legal provisions, with respect to whom the Investor may make decisions at its own discretion; and that the securities would not be purchased for offer or re-sale in the EEA, if this would lead to Exasol AG or any of its affiliates being required to publish a prospectus under Article 3 of the Prospectus Regulation.

Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan.

Some of the information in this announcement may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company. You can identify forward looking statements by terms such as "expect," "believe," "anticipate," "estimate," "intend," "will," "could," "may" or "might," or, in each case, the negative of such terms or other similar expressions. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, risks associated with our industry, as well as many other risks specifically related to the Company and its operations.


19-May-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

back